• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 27, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Free use of Kudos Pro to help researchers keep communicating during pandemic disruption

Bioengineer by Bioengineer
May 1, 2020
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Kudos Innovations Ltd

For immediate release – Oxford, UK – May 1st, 2020 – Kudos, the award-winning service for accelerating research impact, has today announced that it is opening up its leading research communications platform – Kudos Pro – to the global academic community, with complimentary access for 60 days. Over 2,000 researchers around the world have already signed up for complimentary access following an exclusive pre-launch.

With campuses closed and conferences cancelled, Kudos Pro provides the tools needed for academics in all fields to ensure continued communication of critical research insights. For researchers whose work is relevant to COVID-19 and its implications – from diagnosis and treatment to online education – Kudos Pro makes it quick and easy to rapidly communicate research results and recommendations.

Professor Jacquelyn Allen-Collinson, Director of the Health Advancement Research Team at the University of Lincoln, UK comments that: “The new projects pages are an excellent idea, very straightforward and easy to use. The showcase generated also looks good and is user-friendly.”

Kudos Pro is uniquely designed to help research make their work visible not only within the academic community, but also to government, journalists, educators, practitioners, industry and the general public. Researchers can explain, share and showcase their work – helping accelerate broad understanding and uptake of research knowledge and reducing the barriers between experts and their audiences. Kudos Pro also helps distributed teams, working remotely, to collaborate for impact and extend their networks, both within and outside of academia.

Kudos Pro represents a significant step forwards in research communications – helping reach and engage stakeholders at the earliest possible point in the research process, and leveraging a wide range of communication tools and formats, such as social media, infographics, blogs, videos, dissertations and posters. “COVID-19 is stimulating a rapid change in how research is communicated,” says Melinda Kenneway, CEO of Kudos. “Look at some of the innovation we’re already seeing – with global collaboration despite huge restrictions in face-to-face contact, and accelerated industry partnerships. The pace of adoption of new tools has accelerated, which is particularly exciting because of the long-term benefits that this will bring about in terms of how research is communicated.”

Kudos’ wider services are used by over 350,000 researchers from leading institutions, all over the world. Anyone signing up during May will benefit from 60 days’ complimentary use of Kudos Pro.

Coronavirus-related research will also be promoted in Kudos’ newly launched COVID-19 Research Showcase (https://growkudos.com/projects/covid-19), a ‘research hub’ of simple explanations and trustworthy interpretations of the facts, designed to counter fake news around diagnosis, treatment and related topics.

###

Contact:

Charlie Rapple

[email protected]

+44 7595 281786

About Kudos

Over 350,000 researchers have signed up to use Kudos’ services for accelerating and broadening research impact. The company’s toolkits help to showcase research to broader audiences, and provides researchers, research organizations and publishers with guidance and insight around the channels and activities that are most effective for reaching and engaging target audiences. To find out more about Kudos, visit http://www.growkudos.com

Media Contact
Charlie Rapple
[email protected]

Original Source

https://hubs.ly/H0q3hLq0

Tags: Atmospheric ScienceBiologyBusiness/EconomicsChemistry/Physics/Materials SciencesEarth ScienceEducationMedicine/HealthPolicy/EthicsSocial/Behavioral ScienceSpace/Planetary Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Quantum Simulations Reveal the Hidden Electronic Architecture of Methisazone

Quantum Simulations Reveal the Hidden Electronic Architecture of Methisazone

September 26, 2026
From Shrimp Shells to Seaweed: Marine Biopolymers Emerge as Nutraceutical Powerhouses

From Shrimp Shells to Seaweed: Marine Biopolymers Emerge as Nutraceutical Powerhouses

September 26, 2026

Soap Bark Extract and Detergent Molecule Team Up to Shield Steel from Acid

September 26, 2026

New Thienopyridazine-Thiazole Hybrids Show Potent Anticancer Activity in Early Screening

September 26, 2026
Please login to join discussion

POPULAR NEWS

  • Near-Perfect Long Reads Reveal Hidden Mosaicism Left Behind by CRISPR Gene Editing

    29 shares
    Share 12 Tweet 7
  • Machine Learning Meets Forensic DNA: SNPs That Identify Relatives and Separate East Asian Populations

    29 shares
    Share 12 Tweet 7
  • AI-Powered Virtual Screening Uncovers Potent New Dual CDK4/6 Cancer Inhibitor

    29 shares
    Share 12 Tweet 7
  • Oral Wnt-blocking pill plus lenvatinib shows promise in endometrial cancer after immunotherapy fails

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Near-Perfect Long Reads Reveal Hidden Mosaicism Left Behind by CRISPR Gene Editing

Machine Learning Meets Forensic DNA: SNPs That Identify Relatives and Separate East Asian Populations

AI-Powered Virtual Screening Uncovers Potent New Dual CDK4/6 Cancer Inhibitor

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.